Skip to main content

Hovione to invest $170 million across three sites

CDMO Hovione used CPhI Worldwide 2021 in Milan to announce plans to invest $170 million over the years 2020-2022 to expand both capacities and capabilities at three sites in Portugal, Ireland, and New Jersey. About 300 jobs will be created as a result. These reflect its increasing focus on spray drying, high potency and particle engineering.

Thermo Fisher buys GSK Irish site

Thermo Fisher Scientific, owner of Patheon, has agreed to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline (GSK) for about €90 million.
Subscribe to Cork